Transatlantic Charitable Partnership Aims to
Meet the Needs of People Living with Cancer
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today the
launch of its Collaboration for Cancer Prevention, Research and
Support, a transatlantic charitable partnership between the company
and leading European, British and American cancer organizations to
support people living with cancer at all moments of their
journey.
WBA gathered recently with leaders from the European
Organisation for Research and Treatment of Cancer (EORTC),
Macmillan Cancer Support and Susan G. Komen® as they officially
launched the Collaboration and committed to pursue joint projects
with the goal of ensuring a future in which patients have access to
personalized care and support. The three cancer organizations and
WBA agreed to collaborate on initiatives to develop and support
innovative cancer research infrastructure and to share best
practices to improve patient care. WBA is committed to facilitating
these collaborative efforts, supporting their success through
fundraising and driving their impact through its pharmacy
locations, a common touchpoint for people with cancer.
Ornella Barra, WBA Co-Chief Operating Officer and the Chairman
of the company’s Corporate Social Responsibility Committee, said:
“As a global health and wellbeing enterprise, WBA’s purpose is to
help people live healthier and happier lives, and we are committed
to doing all we can to support the fight against cancer. With our
global health reach and broad network of partners, we are uniquely
positioned to act as convener as we bring the best minds and
organizations together to fight the disease. With cancer being
a leading cause of death worldwide, WBA is accelerating and
facilitating support for research and prevention, as well as
assistance for people living with cancer, their loved ones and
caregivers.”
More than 110,000 pharmacists, pharmacy technicians and other
health care service providers and practitioners are among WBA’s
more than 415,000* employees across the world. Its scale and
accessible retail pharmacy locations uniquely position the company
to be a resource for people living with cancer.
Community pharmacists around the world are well-trusted health
care professionals that patients turn to for information and expert
support when facing a cancer diagnosis and therapy. Pharmacists
often dispense crucial medication to cancer patients and provide
advice on its use. Through partnerships with cancer organizations
WBA has been able to expand its cancer care beyond the physical
wellbeing of patients, specially training its employees to also
address the significant emotional impacts of cancer.
The Collaboration builds on WBA’s innovative, ongoing
partnerships with the three cancer organizations.
- In Europe, WBA and EORTC recently
agreed to a five-year extension of their partnership, supporting
the expansion of EORTC’s pan-European cancer research
infrastructure SPECTA (Screening Cancer Patients for Efficient
Clinical Trial Access) to all types of cancer including rare
cancers.
- In the UK, Boots UK and Macmillan
Cancer Support have worked together for 10 years to provide
expertise, information and support to those living with or affected
by cancer. More than 2,000 Boots Macmillan Information Pharmacists
and more than 800 Boots Macmillan Beauty Advisors provide support
in-store for people on how to help manage the effects of cancer and
its treatments. In just one year, these trained pharmacists had
over 92,000 conversations and the beauty advisors delivered more
than 44,500 beauty consultations, providing critical help and
advice to patients in the heart of their communities across the
UK.
- In the U.S., Walgreens and Susan G.
Komen have a long history of working together to provide support
for people with breast cancer with education, patient navigation,
access to quality care and assistance for people undergoing
treatment. Most recently, Komen collaborated with Walgreens on the
launch of Feel More Like You, a program designed to help people
with cancer manage the physical and emotional side effects of their
treatment available through more than 3,000 Walgreens stores.
*Includes equity method investments
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is the first global
pharmacy-led, health and wellbeing enterprise. The company's
heritage of trusted health care services through community pharmacy
care and pharmaceutical wholesaling dates back more than 100
years.
Walgreens Boots Alliance is the largest retail pharmacy, health
and daily living destination across the U.S. and Europe. Walgreens
Boots Alliance and the companies in which it has equity method
investments together have a presence in more than 25 countries and
employ more than 415,000 people. The company is a global leader in
pharmacy-led, health and wellbeing retail and, together with its
equity method investments, has more than 18,500 stores in 11
countries as well as one of the largest global pharmaceutical
wholesale and distribution networks, with more than 390
distribution centers delivering to more than 230,000 pharmacies,
doctors, health centers and hospitals each year in more than 20
countries. In addition, Walgreens Boots Alliance is one of the
world’s largest purchasers of prescription drugs and many other
health and wellbeing products.
The company’s portfolio of retail and business brands includes
Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as
increasingly global health and beauty product brands, such as No7,
Soap & Glory, Liz Earle, Sleek MakeUP and Botanics.
Walgreens Boots Alliance is proud to be a force for good,
leveraging many decades of experience and its international scale,
to care for people and the planet through numerous social
responsibility and sustainability initiatives that have an impact
on the health and wellbeing of millions of people.
Walgreens Boots Alliance is included in Fortune magazine’s 2019
list of the World’s Most Admired Companies and ranked first in the
food and drugstore category. This is the 26th consecutive year that
Walgreens Boots Alliance or its predecessor company, Walgreen Co.,
has been named to the list.
More company information is available at
www.walgreensbootsalliance.com.
About EORTC (European Organisation for Research and Treatment
of Cancer)
EORTC is a unique pan-European clinical cancer research
organization established in 1962 operating as an international
nonprofit association. It develops, conducts, coordinates and
stimulates high-quality translational and clinical trial research
to improve the survival and quality of life of cancer patients.
EORTC research network consists of over 5,300 researchers and
doctors from all disciplines involved in cancer treatment and
research in more than 930 university hospitals in 37 countries. Its
research spans the entire spectrum from translational and
preclinical research to large, prospective, multi-center, phase III
clinical trials that evaluate new cancer therapies and/or treatment
strategies as well as patient quality of life. Today, EORTC has 213
ongoing studies, 27,000 patients in follow-up and outcome data from
over 200,000 cancer patients that form EORTC’s clinical study
database. For further information, please visit the EORTC website:
www.eortc.org.
About Macmillan Cancer Support
Macmillan Cancer Support is the UK’s leading cancer supporter
charity, giving personal, one to one support and care to thousands
of people every day. Funded almost entirely through donations,
Macmillan is there to help everyone in the UK with cancer live life
as fully as they can, providing expert information and physical,
financial and emotional support. So whatever cancer throws your
way, Macmillan is right there with you.
About Susan G. Komen
Susan G. Komen is the world’s largest breast cancer
organization, funding more breast cancer research than any other
nonprofit outside of the U.S. government while providing real-time
help to those facing the disease. Komen has set a Bold Goal to
reduce the current number of breast cancer deaths by 50 percent in
the U.S. by 2026. Since its founding in 1982, Komen has funded more
than $988 million in research and provided more than $2.2 billion
in funding to screening, education, treatment and psychosocial
support programs serving millions of people in more than 60
countries worldwide. Visit komen.org or connect with us on social
at ww5.komen.org/social.
(WBA-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190513005256/en/
Media RelationsUSA / Fiona Ortiz +1 847 315
1959International +44 (0)20 7980 8585
Investor RelationsGerald Gradwell and Jay Spitzer +1 847
315 2922
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Sep 2023 to Sep 2024